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Colloquy: Scientific, Ethical and Policy Challenges
for Public Universities Engaging in Stem Cell
Research*
A University of Minnesota Perspective on SCNT
Research: Past Challenges and Strategy for the
Future
Sr. Vice President Frank B. Cerra, M.D., Senior Vice
President for Health Sciences and McKnight Presidential
Leadership Chair, University of Minnesota
At the University of Minnesota, we are presently engaging
in important and enlightening dialogue surrounding issues of
stem cell research and specifically somatic cell nuclear transfer
(“SCNT”), also called therapeutic or research cloning. There is
no better place for this dialogue than in the halls of a public
research institution; it is here that we must embrace and
respect all views around science and the pursuit of knowledge.
We have a long tradition of doing so, and we continue to do so
in our discussions of SCNT research.
At the University of Minnesota, and in public institutions
of higher learning around the world, it is the faculty who decide
what research they pursue. The University as an institution is
responsible for the creation and fostering of an environment
that maximally encourages and supports research productivity.
As such, we work from the following platform with regard to
© 2008 Frank B. Cerra, Bryan Dowd & Dan S. Kaufman.
* This colloquy is the result of the February 26, 2007 conference
“Creating Stem Cells by Research Cloning: Scientific, Ethical, Legal and
Policy Challenges” held at the University of Minnesota, Minneapolis, MN.
The conference was jointly sponsored by the Consortium on Law and Values in
Health, Environment & the Life Sciences; the Joint Degree Program in Law,
Health & the Life Sciences; and the Academic Health Center. Information
about the conference, including participant biographies and full video is
available at http://lifesci.consortium.umn.edu/conferences/scnt.php.
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research: if the research is in an area of interest of one or more
faculty, if it is within existing legal and regulatory parameters,
if the faculty has resources to conduct the research, if the
University has the facilities and services to support the
research, and if the research has been approved by the
appropriate oversight agencies it can be performed at the
University. However, the research journey is not a wide open
road; not for administration nor for the researchers. It comes
with responsibility.
In 2003, the University of Minnesota made a strategic, and
somewhat political, decision to limit our research portfolio in
the area of SCNT research. After careful internal and external
debate, university policy was adopted that would only allow the
use of public funding for stem cell research if it was also
eligible for federal funding. 1 Further, we would specifically not
allow for the creation of embryos for research regardless of
funding. 2 We limited the source of human embryonal stem
cells to embryos being discarded after in vitro fertilization. 3
Since that time, faculty have come forward interested in the
pursuing the potential promise of therapeutic cloning as a tool
for disease therapies.
We are obligated to re-evaluate
university policy and determine whether in the scientific
community and in our community at large we believe the
creation of embryos for the purposes of this research is worth
the pursuit.
University researchers also play an important role in their
field and must adhere to norms of scientific integrity and
accuracy in reporting of research results. This point has
recently hit close to home for us here at the University of
Minnesota. In early 2007, accusations were made against a
well-known faculty member and then Director of the Stem Cell
Institute that publications regarding adult stem cell findings
1. OFFICE OF REGULATORY AFFAIRS, UNIV. OF MINN., CONDUCTING
RESEARCH WITH HUMAN EMBRYOS OR EMBRYONIC STEM CELLS (2003) (on file
with the University of Minnesota Policy Librarian), available at
http://process.umn.edu/groups/ppd/documents/Policy/stemcell_pol.cfm.
2. OFFICE OF REGULATORY AFFAIRS, UNIV. OF MINN., PROJECT
ADMINISTRATION FOR RESEARCH INVOLVING HUMAN EMBRYOS OR EMBRYONIC
STEM CELL LINES INELIGIBLE FOR FEDERAL/STATE FUNDING (2003) (on file
with the University of Minnesota Policy Librarian), available at
http://process.umn.edu/groups/ppd/documents/procedure/stemcell_proc2.cfm.
3. Id.
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contained duplicated data. 4 A New Scientist reporter alerted
Dr. Catherine Verfaillie to errors in her landmark Nature study
regarding the plasticity of a rare type of adult stem cell. 5 A
university inquiry found that there were duplicated graphs and
data inconsistencies in describing proteins present on the cell’s
surface; however the University panel found no evidence of
scientific misconduct on the part of the research team. 6 As
researchers develop the tools to investigate the science and
report results back to the public, society must be patient about
the progression of the scientific process in new areas of
research and inquiry. The scientific process has served the
research community well for many years and will continue to
evolve as necessary for these developing areas. In science the
truth will be told; it is just time that stands between us and the
understanding of the science.
Society also plays a hand in the pursuit of new knowledge.
As a community of ideas we are called to ensure this healthy,
thorough and fruitful dialogue to advance our understanding of
the science, the value of its potential, and to weigh the ethical
and legal arguments of those scientific and research premises.
The field of medicine will be transformed by the field of
stem cell science. Indeed, here in our institution, stem cell
science serves as one of the primary platforms that enable our
faculty to advance the cures and therapies in areas of research,
such as heart disease, diabetes, brain sciences, and so forth. In
our lifetime, each of us will be touched by the promise and, if
all goes well, the real hope of stem cell biology.

4. Peter Aldhous & Eugenie Samuel Reich, Fresh Questions on Stem Cell
Findings, NEW SCIENTIST, Mar. 24, 2007, at 12.
5. Yuehua Jiang et al., Pluripotency of Mesenchymal Stem Cells Derived
from Adult Marrow, 418 NATURE 41 (2002).
6. Nicholas Wade, Panel Finds Flawed Data In a Major Stem Cell
Report, N.Y. TIMES, Feb. 28, 2007, at A15. Dr. Verfaillie remains a part-time
faculty member at the University of Minnesota. She is now with the Catholic
University of Leuven in Belgium. Id.
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